Brief: AngioDynamics Q2 Adjusted EPS USD -0.05 Vs. IBES Estimate USD -0.07
05/01/2024 12:00
Jan 05 (Reuters) - AngioDynamics Q2 adjusted EBITDA USD 1.8 million. * Q2 adjusted net income USD -2 million * Q2 sales USD 79.1 million vs. IBES estimate USD 82 million * Q2 gross margin 50.9% * Q2 net income USD -29 million * outlook FY gross margin 49-51% * outlook FY sales USD 320-325 million
Recent news on AngioDynamics
See all newsAngioDynamics, Inc. reports results for the quarter ended August 31 - Earnings Summary
AngioDynamics Q1 sales beat on med tech segment growth
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics Inc reports results for the quarter ended May 31 - Earnings Summary